GlassScriptPhysician profile
Rolando Perez
NPI 1174844633
$1,063.79
in general payments reported to CMS, 2019-2025
14 companies · $50.64 in 2025
The $50.64 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.31 · 2021: $122 · 2022: $434 · 2023: $145 · 2024: $263 · 2025: $50.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $353.52 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $248.12 | 2021-2024 | Biktarvy |
| Janssen Products, LP | $142.92 | 2022 | |
| Abbvie INC. | $83.24 | 2022-2025 | |
| Lilly USA, LLC | $63.46 | 2023-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $25.00 | 2024 | Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.93 | 2024 | Jardiance, Tradjenta |
| Emd Serono, INC. | $22.87 | 2022 | |
| Shire North American Group INC | $22.49 | 2019 | |
| Exact Sciences Corporation | $21.52 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $16.05 | 2024 | |
| Janssen Biotech, INC. | $14.85 | 2022 | |
| Nevro Corp. | $13.66 | 2019 | |
| Neuronetics, INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolando Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.